Dr. Morteza Chitsazan, DO

Dr. Chitsazan practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Chitsazan's NPI, 1164513677, was assigned on September 28, 2006. Dr. Chitsazan graduated from WesternU College of Osteopathic Medicine of the Pacific in 1999. Dr. Chitsazan holds California license 20A7819.

Dr. Chitsazan's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Chitsazan's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Chitsazan is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Indio Community Health Center. Dmand AI also links Dr. Chitsazan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chitsazan practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Chitsazan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chitsazan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chitsazan is licensed in California.

Dmand AI lists acute diabetes, anemia, cardiac arrhythmia, electrolyte disorders, kidney failure, lung disease: COPD, asthma or bronchitis, pneumonia and respiratory infection and sepsis among the conditions Dr. Chitsazan treats.

CMS data shows 407 Medicare services from Dr. Chitsazan across 6 procedure codes in 2024, for 141 Medicare patients. Medicare paid $33,632 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. Chitsazan in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 75% are also on Medicaid. Their average risk score is 3.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chitsazan's median patient age at 63, with 42% women.

In 2024, Dr. Chitsazan wrote 319 Medicare Part D claims for 94 patients. 71% of them were for generic drugs. CMS names the drug for 120 of them, across 7 drugs with 11 or more claims each, at $56,565 in total drug cost. In 2023, CMS named 91 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Chitsazan for performance year 2024, reported as part of a group. Dr. Chitsazan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Chitsazan, published from 2014 to 2024. 2014 was the busiest year, with 2. Dr. Chitsazan's most frequent co-authors are Roger Courtney Garrison, DO, Daniel Il-Sun Kim, MD and Huy Duong Au, MD.

CMS Open Payments shows 1 general payment to Dr. Chitsazan from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $72.

Dr. Chitsazan graduated from WesternU College of Osteopathic Medicine of the Pacific in 1999.

Dr. Chitsazan is in network with 2 carriers, including Molina and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.